UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Vulnerabilities in coronavirus glycan shields despite extensive glycosylation

Nature communications, 2020-05, Vol.11 (1), p.2688-2688, Article 2688

2020

Link zum Volltext

Verfügbarkeit prüfen

Protein and Glycan Mimicry in HIV Vaccine Design

Journal of molecular biology, 2019-05, Vol.431 (12), p.2223-2247

2019

Link zum Volltext

Verfügbarkeit prüfen

Structure of the Lassa virus glycan shield provides a model for immunological resistance

Proceedings of the National Academy of Sciences - PNAS, 2018-07, Vol.115 (28), p.7320-7325

2018

Link zum Volltext

Verfügbarkeit prüfen

Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein

Cell reports (Cambridge), 2016-03, Vol.14 (11), p.2695-2706

2016

Link zum Volltext

Verfügbarkeit prüfen

Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers

Cell reports (Cambridge), 2015-06, Vol.11 (10), p.1604-1613

2015

Link zum Volltext

Verfügbarkeit prüfen

Networks of HIV-1 Envelope Glycans Maintain Antibody Epitopes in the Face of Glycan Additions and Deletions

Structure (London), 2020-08, Vol.28 (8), p.897-909.e6

2020

Link zum Volltext

Verfügbarkeit prüfen

Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric Immunogen

Cell reports (Cambridge), 2018-08, Vol.24 (8), p.1958-1966.e5

2018

Link zum Volltext

Verfügbarkeit prüfen

Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies

Nature communications, 2015-06, Vol.6 (1), p.7479-7479, Article 7479

2015

Link zum Volltext

Verfügbarkeit prüfen

A cross-neutralizing antibody between HIV-1 and influenza virus

PLoS pathogens, 2021-03, Vol.17 (3), p.e1009407-e1009407

2021

Link zum Volltext

Verfügbarkeit prüfen

Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization

PLoS pathogens, 2023-10, Vol.19 (10), p.e1011601-e1011601

2023

Link zum Volltext

Verfügbarkeit prüfen

Isomer Information from Ion Mobility Separation of High-Mannose Glycan Fragments

Journal of the American Society for Mass Spectrometry, 2018-05, Vol.29 (5), p.972-988

2018

Link zum Volltext

Verfügbarkeit prüfen

Effector function does not contribute to protection from virus challenge by a highly potent HIV broadly neutralizing antibody in nonhuman primates

Science translational medicine, 2021-03, Vol.13 (585)

2021

Link zum Volltext

Verfügbarkeit prüfen

Signature of Antibody Domain Exchange by Native Mass Spectrometry and Collision-Induced Unfolding

Analytical chemistry (Washington), 2018-06, Vol.90 (12), p.7325-7331

2018

Link zum Volltext

Verfügbarkeit prüfen

Redirecting adenoviruses to tumour cells using therapeutic antibodies: Generation of a versatile human bispecific adaptor

Molecular immunology, 2015-12, Vol.68 (2), p.234-243

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(12)
Glycosylation
(11)
Humans
(9)
Mass Spectrometry
(7)
Animals
(6)
Antibodies
(6)
Antibodies, Neutralizing - Immunology
(6)
Hiv-1 - Immunology
(6)
Human Immunodeficiency Virus
(6)
Cell Biology
(5)
Hek293 Cells
(5)
Hiv
(5)
Hiv-1 - Metabolism
(5)
Polysaccharides - Metabolism
(5)
Biochemistry & Molecular Biology
(4)
General Biochemistry, Genetics And Molecular Biology
(4)
Glycan
(4)
Hiv-1
(4)
Immunology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Vulnerabilities in coronavirus glycan shields despite extensive glycosylation

Protein and Glycan Mimicry in HIV Vaccine Design

Structure of the Lassa virus glycan shield provides a model for immunological resistance

Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein

Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers

Networks of HIV-1 Envelope Glycans Maintain Antibody Epitopes in the Face of Glycan Additions and Deletions

Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric Immunogen

Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies

A cross-neutralizing antibody between HIV-1 and influenza virus

Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization

Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes

Isomer Information from Ion Mobility Separation of High-Mannose Glycan Fragments

Effector function does not contribute to protection from virus challenge by a highly potent HIV broadly neutralizing antibody in nonhuman primates

Signature of Antibody Domain Exchange by Native Mass Spectrometry and Collision-Induced Unfolding

The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization

Redirecting adenoviruses to tumour cells using therapeutic antibodies: Generation of a versatile human bispecific adaptor

Suchergebnisse filtern